Improving Clinical Decision Making with Engaging CME, Tools, & Resources
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Jacob Lang
Josh Davidson, OD, FSLS, FAAO
Mark Dunbar
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Michael A. Klufas, MD
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Kimberly Cockerham, MD
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Why Staging TED Correctly Matters Even When CAS Is Low
Why QoL Measures Change TED Management
Designing Efficient Clinic Workflows for TED Therapy Access
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.